- Home
- DLPN vs EDSA Comparison
DLPN vs EDSA Comparison
Compare DLPN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- EDSA
- Stock Information
- Founded
- DLPN 1996
- EDSA 2015
- Country
- DLPN United States
- EDSA Canada
- Employees
- DLPN N/A
- EDSA N/A
- Industry
- DLPN Other Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- DLPN Consumer Discretionary
- EDSA Health Care
- Exchange
- DLPN Nasdaq
- EDSA Nasdaq
- Market Cap
- DLPN 12.3M
- EDSA 13.8M
- IPO Year
- DLPN N/A
- EDSA N/A
- Fundamental
- Price
- DLPN $1.25
- EDSA $2.08
- Analyst Decision
- DLPN Strong Buy
- EDSA Strong Buy
- Analyst Count
- DLPN 1
- EDSA 2
- Target Price
- DLPN $5.00
- EDSA $13.00
- AVG Volume (30 Days)
- DLPN 29.3K
- EDSA 15.0K
- Earning Date
- DLPN 08-13-2025
- EDSA 08-08-2025
- Dividend Yield
- DLPN N/A
- EDSA N/A
- EPS Growth
- DLPN N/A
- EDSA N/A
- EPS
- DLPN N/A
- EDSA N/A
- Revenue
- DLPN $48,618,803.00
- EDSA N/A
- Revenue This Year
- DLPN $6.57
- EDSA N/A
- Revenue Next Year
- DLPN $18.10
- EDSA N/A
- P/E Ratio
- DLPN N/A
- EDSA N/A
- Revenue Growth
- DLPN 0.31
- EDSA N/A
- 52 Week Low
- DLPN $0.75
- EDSA $1.55
- 52 Week High
- DLPN $2.00
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- DLPN 65.36
- EDSA 55.28
- Support Level
- DLPN $1.07
- EDSA $1.99
- Resistance Level
- DLPN $1.24
- EDSA $2.11
- Average True Range (ATR)
- DLPN 0.08
- EDSA 0.11
- MACD
- DLPN 0.01
- EDSA 0.02
- Stochastic Oscillator
- DLPN 84.00
- EDSA 72.41
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.